SCRIB and breast carcinoma: Conversely, disabling SCRIB, e.g. by dislocation from the plasma membrane into the cytoplasm, impairs the SCRIB influence on the Hippo pathway and leads to increased TAZ stability, nuclear localization of TAZ, increased breast cancer cell proliferation and breast cancer growth37,41.